Capricor Therapeutics (CAPR) announced the appointment of Michael Binks as Chief Medical Officer, effective immediately. Binks has 25 years of experience leading global clinical development and translational research across the pharmaceutical and biotechnology sectors. He previously held senior leadership roles at Pfizer and GlaxoSmithKline. Most recently, Binks served as Vice President and Head of Rare Disease Clinical and Translational Research in Worldwide Research, Development and Medical at Pfizer.
"Michael is an outstanding addition to Capricors leadership team as we advance deramiocel toward potential commercialization for the treatment of Duchenne muscular dystrophy and explore future pipeline expansion opportunities," said Linda Marbn, Chief Executive Officer of Capricor.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.